1. Home
  2. CORT vs EPAM Comparison

CORT vs EPAM Comparison

Compare CORT & EPAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

N/A

Current Price

$63.63

Market Cap

7.6B

Sector

Health Care

ML Signal

N/A

Logo EPAM Systems Inc.

EPAM

EPAM Systems Inc.

N/A

Current Price

$153.22

Market Cap

7.9B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
CORT
EPAM
Founded
1998
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
7.6B
7.9B
IPO Year
2001
2011

Fundamental Metrics

Financial Performance
Metric
CORT
EPAM
Price
$63.63
$153.22
Analyst Decision
Buy
Buy
Analyst Count
5
19
Target Price
$142.60
★ $172.88
AVG Volume (30 Days)
1.2M
★ 1.3M
Earning Date
11-03-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
1.13
★ 6.00
Revenue
$761,407,000.00
★ $1,450,448,000.00
Revenue This Year
$52.09
$3.65
Revenue Next Year
$44.73
$3.32
P/E Ratio
$57.37
★ $25.10
Revenue Growth
12.79
★ 25.02
52 Week Low
$28.66
$73.06
52 Week High
$126.38
$222.53

Technical Indicators

Market Signals
Indicator
CORT
EPAM
Relative Strength Index (RSI) 20.65 57.47
Support Level $30.24 $125.75
Resistance Level $122.93 $168.21
Average True Range (ATR) 4.77 6.88
MACD -0.14 -1.63
Stochastic Oscillator 1.89 58.40

Price Performance

Historical Comparison
CORT
EPAM

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.

About EPAM EPAM Systems Inc.

EPAM Systems is a global IT services firm with a focus on platform engineering, software development, and consulting services. The company used to host large engineer bases in Ukraine, Belarus, and Russia, but it now delivers from various locations across different continents. EPAM's largest market is North America, which represents approximately 60% of revenue.

Share on Social Networks: